113 results
CORRESP
ONCT
Oncternal Therapeutics Inc
19 Jan 11
Correspondence with SEC
12:00am
and other countries in Asia, and before the European Patent Office designating Germany, Great Britain, Spain, France, Italy and other European Union … , Italy and other European Union countries, as well as pending patent applications in certain other countries outside those regions, related to the use
8-K
ONCT
Oncternal Therapeutics Inc
13 Dec 06
GTx Announces Registered Direct Common Stock Offering of $60.8 Million
12:00am
agreement. Similarly, Ipsen has agreed to purchase from Orion ACAPODENE® tablets for clinical testing and commercial sale in the European Union … for human use in the United States and other major countries located outside the European Union during the term of Orion’s patents covering
8-K
ONCT
Oncternal Therapeutics Inc
7 Sep 06
Regulation FD Disclosure
12:00am
license to develop and market GTx’s Acapodene® (toremifene citrate) in all indications except breast cancer, in Europe (European Union, Switzerland
8-K
EX-99.1
46f6u2 msr
2 Nov 09
GTx Receives Complete Response Letter from FDA for Toremifene 80 mg New Drug Application
12:00am
8-K
EX-99.1
kdv 267azy6evf
4 Apr 14
GTx Announces Departure of CEO
12:00am
8-K
3cx0j pfi8cc
2 Mar 11
Termination of a Material Definitive Agreement
12:00am
424B5
ed0 ruen5c2fh206ur
14 Dec 06
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
9mtuck71q
11 Dec 09
GTx Announces Reduction in Force
12:00am